A novel approach to maintain gut mucosal integrity using an oral enzyme supplement
- PMID: 25203888
- PMCID: PMC5034572
- DOI: 10.1097/SLA.0000000000000916
A novel approach to maintain gut mucosal integrity using an oral enzyme supplement
Abstract
Objective: To determine the role of intestinal alkaline phosphatase (IAP) in enteral starvation-induced gut barrier dysfunction and to study its therapeutic effect as a supplement to prevent gut-derived sepsis.
Background: Critically ill patients are at increased risk for systemic sepsis and, in some cases, multiorgan failure leading to death. Years ago, the gut was identified as a major source for this systemic sepsis syndrome. Previously, we have shown that IAP detoxifies bacterial toxins, prevents endotoxemia, and preserves intestinal microbiotal homeostasis.
Methods: WT and IAP-KO mice were used to examine gut barrier function and tight junction protein levels during 48-hour starvation and fed states. Human ileal fluid samples were collected from 20 patients postileostomy and IAP levels were compared between fasted and fed states. To study the effect of IAP supplementation on starvation-induced gut barrier dysfunction, WT mice were fasted for 48 hours +/- IAP supplementation in the drinking water.
Results: The loss of IAP expression is associated with decreased expression of intestinal junctional proteins and impaired barrier function. For the first time, we demonstrate that IAP expression is also decreased in humans who are deprived of enteral feeding. Finally, our data demonstrate that IAP supplementation reverses the gut barrier dysfunction and tight junction protein losses due to a lack of enteral feeding.
Conclusions: IAP is a major regulator of gut mucosal permeability and is able to ameliorate starvation-induced gut barrier dysfunction. Enteral IAP supplementation may represent a novel approach to maintain bowel integrity in critically ill patients.
Conflict of interest statement
The authors declare no conflicting financial interests.
Figures
Similar articles
-
A role for intestinal alkaline phosphatase in preventing liver fibrosis.Theranostics. 2021 Jan 1;11(1):14-26. doi: 10.7150/thno.48468. eCollection 2021. Theranostics. 2021. PMID: 33391458 Free PMC article.
-
Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition.Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3551-6. doi: 10.1073/pnas.0712140105. Epub 2008 Feb 21. Proc Natl Acad Sci U S A. 2008. PMID: 18292227 Free PMC article.
-
Intestinal alkaline phosphatase targets the gut barrier to prevent aging.JCI Insight. 2020 Mar 26;5(6):e134049. doi: 10.1172/jci.insight.134049. JCI Insight. 2020. PMID: 32213701 Free PMC article.
-
Protective Properties of Intestinal Alkaline Phosphatase Supplementation on the Intestinal Barrier: Interactions and Effects.J Agric Food Chem. 2024 Jan 10;72(1):27-45. doi: 10.1021/acs.jafc.3c05119. Epub 2023 Nov 14. J Agric Food Chem. 2024. PMID: 37964463 Review.
-
Intestinal alkaline phosphatase: novel functions and protective effects.Nutr Rev. 2014 Feb;72(2):82-94. doi: 10.1111/nure.12082. Epub 2013 Dec 9. Nutr Rev. 2014. PMID: 24506153 Review.
Cited by
-
In-Depth Genome Characterization and Pan-Genome Analysis of Strain KMM 296, a Producer of Highly Active Alkaline Phosphatase; Proposal for the Reclassification of Cobetia litoralis and Cobetia pacifica as the Later Heterotypic Synonyms of Cobetia amphilecti and Cobetia marina, and Emended Description of the Species Cobetia amphilecti and Cobetia marina.Biomolecules. 2024 Feb 6;14(2):196. doi: 10.3390/biom14020196. Biomolecules. 2024. PMID: 38397433 Free PMC article.
-
A foundational approach to culture and analyze malnourished organoids.Gut Microbes. 2023 Dec;15(2):2248713. doi: 10.1080/19490976.2023.2248713. Epub 2023 Sep 19. Gut Microbes. 2023. PMID: 37724815 Free PMC article.
-
Increased Drop in Activity of Alkaline Phosphatase in Plasma from Patients with Endocarditis.Int J Mol Sci. 2023 Jul 21;24(14):11728. doi: 10.3390/ijms241411728. Int J Mol Sci. 2023. PMID: 37511497 Free PMC article.
-
Intestinal barrier dysfunction: an evolutionarily conserved hallmark of aging.Dis Model Mech. 2023 Apr 1;16(4):dmm049969. doi: 10.1242/dmm.049969. Epub 2023 May 4. Dis Model Mech. 2023. PMID: 37144684 Free PMC article. Review.
-
Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis.Blood Adv. 2023 Sep 12;7(17):5137-5151. doi: 10.1182/bloodadvances.2023009960. Blood Adv. 2023. PMID: 37083597 Free PMC article.
References
-
- Merrell RC. The abdomen as source of sepsis in critically ill patients. Crit Care Clin. 1995;11:255–272. - PubMed
-
- Doig CJ, Sutherland LR, Sandham JD, et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med. 1998;158:444–451. - PubMed
-
- Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med. 2001;29:2264–2270. - PubMed
-
- Doig GS, Heighes PT, Simpson F, et al. Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med. 2009;35:2018–2027. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
